Solesence, Inc. Common Stock SLSN Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.79M— | —— | -$4.39M-67.4% | -$2.62M— | ||
| $897K-3.3% | $928K+25.1% | $742K+30.9% | $567K+24.9% | ||
| $575K-20.7% | $725K-6.2% | $773K+23.7% | $625K+291% | ||
| —— | —— | —— | —— | ||
| -$1.76M-117% | $10.24M— | —— | —— | ||
| -$5.38M-324% | $2.4M— | —— | —— | ||
| -$2.02M-151% | $3.99M+2,832% | -$146K— | —— | ||
| -$662K— | —— | $219K+598% | -$44K-113% | ||
| -$4.64M— | —— | —— | $744K-31.6% | ||
| —— | -$163K— | —— | $652K— | ||
| —— | $1.97M+198% | -$2.01M— | —— | ||
| $2.14M-53.0% | $4.56M+334% | $1.05M-62.8% | $2.82M+50.6% | ||
| -$2.14M+53.0% | -$4.56M-334% | -$1.05M+62.8% | -$2.82M-50.6% | ||
| —— | —— | —— | —— | ||
| $323K-84.8% | $2.12M— | —— | $182K— | ||
| —— | —— | —— | —— | ||
| —— | —— | $2.59M-59.9% | $6.47M+966% | ||
| —— | -$313K— | —— | —— | ||
| $1.02M+60.4% | $637K-15.3% | $752K+126% | $333K+52.8% | ||
| -$4.64M— | —— | —— | $744K-31.6% | ||
| —— | -$163K— | —— | $652K— | ||
| -$662K— | —— | $219K+598% | -$44K-113% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | $29.59M+15.8% | ||
| —— | —— | —— | $971K— | ||
| —— | -$163K— | —— | $652K— | ||
| —— | $1.02M— | —— | —— | ||
| $325K— | —— | —— | —— | ||
| —— | —— | —— | -$4.79M-1,171% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Solesence, Inc. Common Stock generate?
- Solesence, Inc. Common Stock (SLSN) generated -$8.9M in operating cash flow over the trailing twelve months.
- What is Solesence, Inc. Common Stock's free cash flow?
- After $2.8M of capital expenditures, Solesence, Inc. Common Stock's free cash flow was -$11.1M over the trailing twelve months, down 34.7% year over year.
- Where does Solesence, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Solesence, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
